Sector revisions Mesa Laboratories, Inc.

Stocks

Real-time Estimate Cboe BZX 08:55:03 09/09/2026 pm IST			5-day change	1st Jan Change
124.82 ^USD	+0.87%		-4.37%	+59.17%

11/08	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
11/08	Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005.	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	MESA LABORATORIES, INC.							2
	ABBOTT LABORATORIES							24
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							15
	TERUMO CORPORATION							13
	STERIS PLC							8
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	GLOBUS MEDICAL, INC.							13
	INSULET CORPORATION							22
	BIO-RAD LABORATORIES, INC.							5
	Average							15
	Weighted average by Cap.							19

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!